4 Reasons Why Orphan Drugs Require a Specific Packaging Line
4 Reasons Why Orphan Drugs Require a Specific Packaging Line How to find the packaging facility that fits your orphan drug product ? Orphan drugs are developed to serve small, highly specific patient populations. They represent some of the most innovative and patient-critical therapies in the pharmaceutical industry. Yet despite their uniqueness, many orphan drugs […]
MucoTabS Reaches a Key Milestone with Official Patent Filing
MucoTabS Reaches a Key Milestone with Official Patent Filing Major milestone for MucoTabS, marked by the official filing of a patent securing this innovative technology Conducted as part of Pauline Tarlet’s doctoral research, supervised by Vanessa Bourgeaux (Head of Innovation at Skyepharma) and formerly by Marion Quaillet (Head of Project Managers), this program is carried […]
Skyepharma : The French CDMO Advances Strategic Growth Through Leadership and Shareholder Transition
Skyepharma : The French CDMO Advances Strategic Growth Through Leadership and Shareholder Transition Bertrand Simon and Hervé Letoublon acquire 100% of the company’s shares, Sébastien Mas becomes the new CEO of Skyepharma Skyepharma, a French CDMO (contract development and manufacturing organization), expert in solid oral forms and complex projects, has a remarkable story to tell. […]
Skyepharma Scientific Symposium 2025: “Advances in Overcoming Oral Dosage Form Development Challenges”.
Skyepharma’s Scientific Symposium 2025: “Advances in Overcoming Oral Dosage Form Development Challenges”. Julie AUFFRAY, Vanessa BOURGEAUX, Pascal GEORGE, Stéphanie BRIANCON, Claudia GAMA, Julien LEROUDIER, Hassan BENAMEUR, Quentin BOOULAY From groundbreaking advancements in drug delivery technologies to engaging discussions with industry leaders. Skyepharma has been a specialist in complex oral solid dosage forms for over 25 […]